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AN-AEA11A is frequently observed in cancer patients and also in animals bearing
transplantable or induced tumours this association is the subject of a recent
review by Price and Cxreenfield (1958). It is probable that both decreased ery-
thropoiesis and increased erythrocyte destruction contribute to the reduction in
haemoglobin concentration, haematocrit value or red cell volume observed in
anaemias associated with cancer. However, evidence has accumulated that an in-
creased rate ofdestruction ofthe circulating red cells is common in human cancer.
Thus Berlin (I951) demonstratedby theAshby differentialagglutinationtechnique
an iiiereased rate ofdestruction oftransfused normal cells inpatients with myeloid
or lymphatic leukaemia. An increased rate of destruction of the patient's own
circulating red cells labelled with glycine-2_14C was found by Berlin, Lawrence
and Lee (1954) in leukaemia. Hyman, Gellhorn and Harvey (1956), using both
the Ashby technique and the transfusion of cells labelled with 51Cr found an
increased rate of destruction of cells transfused from normal donors to patients
with carcinomata and other neoplasms, whereas cells transfused from cancer
patients to normal volunteers had a normal or near-normal life span. Hence they
argued the absence of any intrinsic defect in the red cells of cancer patients.
Miller, Chodos, Emerson and Ross (1956) also demonstrated by the Ashby and
the 5ICr-techniques an increased rate of destruction of red cells transfused from
normal subjects to patients with cancer of various sites or autotransfused to such
patients.
The results of studies on animals bearing transplantable or induced tumours
have been more conflicting. Ultman, Fish and Hyman (1956), in studies of 5ICr-
survival in rabbits bearing the Brown-Pearce or X112 carcinoma, failed to reveal
any increased destruction of red cells except in animals with severe infection.
Ehrenstein (1958) used glycine-2-14C to study the life span of the circulating red
cells in mice bearing the Ehrlich ascites carcinoma and found increased red cell
dest-ruction of the random type in tumour-bearing animals. Greenfield, Godfrey
and Price (1958), USilIg 59Fe-labelled cells, also observed increased red cell destruc-
tion in rats bearing Lymphosarcoma 2788, Hepatoma 3683, the Yoshida ascites
tumour and the Harderian gland Carcinoma 2226. They fouiid that as red cell
destruction proceeded, 59Fe accumulated within the ttimour. In all of these
tumours, haemorrhage or thrombosis was observed. In the mouse Fibrosarcoma
HE 8971 and Hepatoma 134 (ascites) and the rat Fibrosarcoma 4956, in which
there was little or no haemorrhage or thrombosis, anaemia and loss of labelled
red cells was small and did not occur until the late stages of tumour growth. In
further studies by the same group, Greenfield, Sterling and Price (1958) transfused
5'Cr-labelled red cells to rats bearing the Lymphosarcoma R 2788 and were able.?-1) P. lid " RED CELL DESTRUCTION IN TUMOUR BEARING RATS
to recover from the tumournearly all the 5'Cr lost from the blood ; they concluded
that increased red cell destruction was the consequence of vascular injury in the
neighbourhood of the tumour. Price, Greenfield, Sterling and MacCardle (1959)
transfused mixtures of 5'Cr- and 59Fe-labelled red cells to rats with Lymphosar-
coma R 2788 and found that the subsequent distributions of the two isotopes
within the tumour were similar, uptake being greatest in haemorrhagic areas, less
in necrotic areas and almost negligible in white viable tumour. In this tumour,
haemorrhage into the surrounding connective tissue is an important phenomenon.
The extent of increased red cell destruction in other tumours could be correlated
with theirhistological appearance. Thus in Fibrosarcoma 4956, littlehaemorrhage
was observed and increased red cell destruction was not detected until the tumour
had become massive and ulceration of the skin had occurred.
In the investigations described below, red cell destruction has been studied
by the 5'Cr- and "Fe-techniques in rats of the
" August
" strain bearing the
transplantable mammary adenocarcinoma R 2426, in which neither haemorrhage
nor necrosis are observed. Particular interest was attached to this tumour since
a haemolytic episode in the host animal had been observed to follow its implanta-
tion. Preliminary reports of these studies have already been published (Belcher,
1958. 1959).
MATERIALS AND METHODS
Rat8.-Rats of the pure-line
" August
" strain ofweight 100-200 g. were used
throughout. They were maintained on Medical Research Council Diet No. 41 and
water ad libitum. Frequent observations on splenectomised animals failed to
reveal any latent Bartonella muri8 infection.
Tran8plantation of tumour.-Tumour R 2426 was transplanted at intervals of
about 4 weeks. Implantation of tumour was carried subcutaneously under aseptic
conditions through a trochar inserted into the left abdominal wall, the site of
implantation being afterwards closed by a small suture clip. Four weeks after
implantation, when transplantation was again due, the growing tumour was firm
and round with a maximum diameter of about 2 cm. On sectioning, it was
normally found to be white and viable throughout, with no evidence of necrotic
or haemorrhagic areas.
Studie8 with5l6'r-labelled red ce118
Red cell survival studies with 5'Cr were made as described by Belcher and
Harriss (1959). In order to reduce the possibility of uncontrolled transfusion
reactions, transfusion of blood was carried out under aseptic conditions between
male litter mates, one member of each litter acting as donor, the others as reci-
pients. In studies with 5ICr, the red cells of donor animals were labelled in vitro
with 5'Cr as follows: 2 ml. of blood were withdrawn by cardiac puncture into a
syringe containing 0-1 ml. heparin (" Pularin ", Evans Medical Supplies Ltd.), and delivered into agraduated test tube. One ml. ofacid-citrate dextroge-solution
and I ml. of a solution of sodium chromate 5'Cr in isotonic saline containing about 50 /te./ml. -51Cr (specific activity about 10 1,tc.1pg. Cr) were added. The
mixture was allowed to stand for 30 minutes with occasional shaking. It was then
gently centrifuged, the supernatant diluted plasma pipetted off and the cells
resuspended in isotonic saline, the final volume being readjusted to 2 ml. The1)-)k, E. H. BELCHER AND SHIRLEY M. SIMPSON
labelled cell suspension was further diluted with isotonic saline if desired. Of the
added 51Cr, 90-95 per cent entered the red cells.
Portions ofthe labelled cell suspension 0-5 ml. in volume were injected without
delay into litter mate recipients, injection being carried out either intravenously
into a lateral tail vein or intraperitoneally. At daily intervals thereafter, the ex-
treme tip of the tail of each recipient was cut under light ether anaethesia and a
0-02' ml. blood sample taken into a haemoglobin pipette and delivered into 5 ml.
ammoniated distilled water for haemoglobin estimation. Haemoglobin was
estimated colorimetrically as HbO2 in the haemolysed blood samples. These were
then transferred to 5 inch diameter sample tubes and assayed for 5'Cr in a well 8
scintillation counter coupled to a scaler through a linear amplifier and single
channelpulseheight discriminator/analyser. The5'Cr concentrations in successive
samples of blood were expressed as percentages of that of the sample taken from
the same animal on the first day after transfusion and the result corrected for
the increase in blood volume with increase in weight of the animal during the
period of observation (Belcher and Harriss, 1957).
Studies of 51Cr-distribution in the tissues were made as described by Belcher,
Lamertoii and Harriss (195,S). Recipient animals were killed by cervical fracture
uiider ether anaesthesia. They were then exsanguinated as completely as possible
by opening the thorax, excising the left lung ai-id injecting isotonic saliiie into the
left ventricle of the heart, diluted blood being removed as it accumulated in the
thoracic cavity. The carcasses were then carefully dissected and selected tissues
removed to A inch diameter sample tubes for 5ICr-assay. Small corrections were 8
applied for the variation in efficiency of the scintillation counter with sample
volume.
k'*iidies with 59Fe-labelled red cell-s
Red cell survival studies with 5We were made as described by Belcher aiid
Harriss, 1959. The circulating red cells of donor animals were labelled in vivo
with59Fe as follows ; 10 pC. 59Fe (specificactivity 1-5 /tc.Ilig. Fe) as ferric chloride
in 0-5 ml. I per cent w/v sodium citrate solution were injected intravenously to
each donor. After an interval of 3 days to allow cells labelled in theerythropoietic
tissues to emerge into the circulation, about 2 ml. of blood were withdrawn by
cardiac puncture from each donor into a heparinised syringe and delivered into a
graduated test tube. The 59Fe-labelled red cells were further labelled in vitro with
51(.',r as described above if desired. Portions of labelled cell suspension 0-5 ml. in
volume were theninjectedintravenously into litter materecipients. Daily 0-02 nil.
blood samples were taken from the cut tails of the recipient animals as already
described, haemolysed in 5 ml. ammoniated distilled water and transferred to
'85 inch diameter sample tubes for radioactive assay. To suppress re-utilisation of
59Fe from destroyed red cells by the erythropoietic tissues daily injections of
0-1 ml./100 g. body weight of an iron-dextran complex (" linferon ", Bengers
Laboratories Ltd.) containing 50 mg./ml. Fe were given intramuscularly through-
out studies of red cell survival of 59Fe-labeHed cells.
In the radioactive assay of samples in single tracer experiments with 5ICr or
59Fe alone, thediscriminator/analyser unit was operated as a simple discriminator.
In double tracer experiments with 5'Cr and 59Fe, samples were first assayed for
"We by using the unit as a discriminator set at a level such that the system was
almost completely insensitive to 5'Cr. Samples were then assayed for 5'Cr usingI
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the unit as an analyser aligned on the peak of the 51Cr gamma spectrum, a cor-
rection being applied for the small contribution to the total counting rate due to
"Fe on the basis of the already determined 59Fe content of the sample.
RESULTS
Respon-se of
" Augu8t
" rat8 to implantation of tumour R 2426
August rats receiving subcutaneous implants of tumour R 2426 undergo an
acute haemolytic episode between 10 and 15 days after implantation, at which
time the growing tumour bas the size of a small pea. During theepisode, which is
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FiG. I.-Blood haemoglobin in
" August
" rats receiving subcutaneous implants of tumour R 2426.
accompanied by haemoglobinuria and which may be fatal, the haemoglobin concentration of the circulating blood falls to about 5 g.1100 ml. (Fig. 1). If the
animal survives, thehaemoglobin concentration returns to normal within a further
I0 days.
Survival of red cellsfrom normal donors labelled with 5'Cr andtransfused to tumour-
bearing recipients
lfred cells from a normal donor are labelled with 5'Cr and 0-5 ml. ofthe labelled
cell suspension transf-Lised to a litter mate recipient animal which is then given a
tumour implant, the fate ofthe circulating red cells during the haemolytic episode
can be followed (Fig. 2). Up to the start ofthehaemolyticepisode, red cell survival
is within the normal limits quoted by Belcher and Harriss (1959), but during the
episode almost all of the transfused cells are removed, the 5lCr-concentration in
the blood falling more steeply than the haemoglobin concentration which is to
some extent maintained by compensatory erythropoiesis.228 E. H. BELCHER AND SHIRLEY M. SIMPSON
Red cells from normal donors labelled with 51Cr and transfused to tumour-
bearing recipients after implantation of tumour but before the haemolytic episode
or during its development are similarly removed from the eirculatioii during the
episode (Fig. 3). However, if cells from normal donors are labelled with 5'Cr and
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*FiG. 2.-Blood haemoglobin and 5'Cr-concentration n tumour-bearing "August" rats
transfused with 0-5 MI. 5'Cr-labelled red cells from no-nal litter-mate donors 4 days after
implantation with tumour R 2426.
Range of 5'Cr-concentration in normal
"August
" rats transfused with 5'Cr-labelled
cells from litter-mate donors.
transfused to tumour-bearing recipients which have already suffered their haemo-
lytic episode and are in recovery fromit, the labelled cells are notrapidlyremoved,
red cell destruction being only slightly, albeit Significantly, more rapid than in
normal animals (Fig. 4). At this time therefore, it appears either that the concen-
tration ofthehaemolytic agent in the host animal is reduced or that some mechan-
ism is operating to reduce its effect on the circulating red cells.
* Tn this and subsequent figures, except Fig. I1, the graph lines shown by solid and open points
refer to two identically treated rats.RED CELL DESTRUCTION IN TUMOUR BEARING RATS 229
Survival of red cellsfrom tumour-bearing donors labelled with 5'Cr and transfused to
tumour-bearing recipients
Red ceHs from tumour-bearing donors labelled with 5'Cr and transfused to
tumour-bearing recipients before or during the development of the haemolytic
episode are rapidly removed during the episode, as are cells from normal donors.
D'sys
FIG. 3.-Blood haemoglobin and 5'Cr-concentration in tumour-bearing "August" rats transfused with 0
- 5 ml. -"Cr-labelled red ceRs from normal litter-mate donors 13 days after iinplantation with tumour R 2426.
I 7 7 ZI Range of5'Cr-concentration innormal
"August
" rats transfusedwith5'Cr-labelled
ceils from litter-mate donors.
When cells fromtumour-bearing animals in recoveryfrom theirhaemolyticepisode
are labelled and transfused to other tumour-bearing animals in recovery, red cell destruction appears within normal limits (Fig. 5). However, in this situation the transfused cells have agrossly abnormal age distribution with a preponderance of
young cells, since most of the donor's circulating red cells were destroyed during the episode. Under these circumstances, the observation of apparently normalj...*
t
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,"Cr-survival indicates a slightly increased red cell destruction rate, such as is
observed when cells are transfused from normal donors to tumour-bearing reci-
pients in recovery.
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FIG. 4.-Blood haemoglobin and -"Cr-concentration in tumour-bearing
" August
" rats
transfused with 0
- 5 ml. 5'Cr-labelled red cells from normal litter-mate donors 14 days after
iinplantation with tumour R 2426.
[,- / .,/ Range of5'Cr-concentration in normal
"August
" rats transfLised with 5'Cr-labelled
cells from litter-mate donors.
-y Survtval of red cell-s om tumour-bearing donor-s doubly labelled with 9Fe and 5ICr
and tran-sfu-sed to tumour-bearing recipient8
It is of interest whether red cells are destroyed during the haemolytic episode in a random fashion without regard to age, or whether older cells are more rapidly destroyed than younger ones. To study this question, a donor rat implanted with
tumour 3 dayspreviously was given an intravenous injection of 10 /tc. "Fe. Three
days later, when the 59Fe-labelled red cell precursors had emerged into the circu-20
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lating blood, blood was withdrawn from the donor animal by cardiac puncture
and labelled in vitro with 5'Cr. The labelled red cell suspension thus obtained
contained cells of all ages labelled with 5'Cr and included a sin le cohort of young 9 V 1-1
cells labelled with "Fe. This suspension was then used for survival studies in
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FiG. 5.-Blood haemoglobin and 5'Cr-concentration in tumour-bearing
" August
" rats
transfused with 0
- 5 ml. -"Cr-labelled red cefls fromtumour-bearinglitter-mate donor 14days after implantation with tumour R 2426.
/ I/ / Range of5'Cr-concentration in normal
" August
" rats transfused with 5'Cr-labeued
ceRs from litter-mate donors.
litter materecipients (Fig. 6). Despite thedailyinjection ofiron-dextran to block
re-utilisation, some of the 59Fe from destroyed red ceRs is incorporated into the
haemoglobin of red cell precursors in the erythropoietic tissues and thus returned
to the circulationduringthehaemolyticepisode. Forthis, reason, the"Fe-survival
curve falls less rapidly than does that for 5'Cr. Apart from this observation, how-
18232) E. H. BELCHER AND SHIRLEY M. SIMPSON
ever no significant difference can be observed between the survival curves for
5'Cr and"Fe-labelled red ceRs during the episode. It thus appears that cells are
destroyed at random, withoutregard to age, during this episode.
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Sites of destruction of red cellsfrom tumour-bearing donors labelled with 5'Cr and
transfused to tumour-bearing recipients
Toidentify the chiefSiteg ofred cell destructionduring thehaemolyticepisode,
red cells from tumour-bearing donors were labelled with 5'Cr and transfused to
tumour-bearing recipients before the development ofhaemolysis. During or after
the subsequent episode, recipient animals were sacrificed and exsanguinated.233 RED CELL DESTRUCTION IN TUMOUR BEARING RATS
TABLE I.-Distribution of 51Cr in Tissues and Excreta of Four
" August
" Rats,
Bearing Tumour R 2426, Transfused with 5'Cr-labelled Cells from Normal
Litter-mate Donors 5-6 days After Implantation of Tumour and Sacrificed
During or After Subsequent Haemolytic Epi8ode.
Interval between implantation 5 6
and transfusion (days)
Interval between implantation 11 15
and assay (days)
-11Cr content 51Cr content
Tissue (% injected dose) (% injected dose)
f, A-
I A
Blood 18-0 17-0 13-0 14-4
Spleen 15-0 10.0 12-0 13-5
Liver 27-0 23-0 12-0 27-0
Kidneys 5-0 2-5 1.5 5-5
Lungs 1.5 0-8 0-4 1-0
Tumour 0-1 0-2 0.1 0.1
Other tissues 17-3 17-8 5-4 8-0
Total urine 4-5 14-0 25-0 23-7
Total faeces 11.0 8-0 14-0 6-2
Recovery 99-4 93-3 93-4 99-4
Selected tissues were then dissected out and assayed for 51Cr. Results are sum-
marised in Table 1. It can be seen that 51Cr accumulates in both the liver and
the spleen, the highest concentration, but not necessarily the greatest amount
being found in the spleen. In contrast to the observations of Greenfield, Sterhng
and Price (1958), uptake in the tumour is negfigible or extremely small. The
livers and spleens of animals sacrificed after theirhaemolytic episode are found to
be enlarged and engorged with blood. It thus appears that the chief sites of red
cell destruction during the episode are the liver and spleen, which together
account for some 40 per cent of the radioactivity lost from the circulating blood.
Red cell destruction due to haemorrhage in the vascular bed of the tumour is
absent or extremely small.
Survival of red cellsfrom tumour-bearing donors labelled with 51Cr and transfused to
normal recipients
August rats receiving transfusions ofblood from donor animalsbearing tumour
R 2426 undergo a haemolytic episode similar to that observed in animals re-
ceiving implants of tumour. Fig. 7-10 show the results ofexperiments in which
blood was taken fromtumour-bearing donors at 4, 9, 14 and 19days afterimplan-
tation of tumour and labelled with -51Cr ; 0-5 ml. of the labelled red cellsuspension
or of the supernatant plasma was then trangfused intfavenously to normal litter
inate recipients. When transfusion of red cells is carried out at 4 days after
implantation, at which time thegrowing tumour is scarcelypalpable (Fig. 7), the
haemolytic episode ispreceded by a period ofnormal survival ofthe labelled cells.
During the episode, both the transfused ceRs and the donor's own circulating red
cells are destroyed simultaneously. Cells transfused at 9 days, shortly before the
donor's ownhaemolytic episode (Fig. 8), cause a more prompt haemolysis, though
a period of normal survival can still be seen. At 14 days (Fig. 9), haemolysis in
the recipient is almost immediate and frequently fatal.234 E. H. BELCHER AND SHIRLEY M. SIMPSON
When transfusion ofceRs is carried out at 19days afterimplantation, however,
when the donor is in recovery (Fig. IO), a different pattern is observed; a haemo-
lytic episode takes place in the recipient about 4 days after transfusion, but this
episode affects only the recipient's ow-n cells and the survival of the transfused
labelled cells appears onlyshghtly less than normal. It must again beemphasised
that since the age distribution of these labelled cells is abnormal, with a pre-
ponderance of young ceRs, the observation of a nearly normal 5'Cr-survival indi-
cates that the labelled cells in fact have a shortened life span. Nevertheless, it is
-4-M,
r.
(L)
0
$.4
(1)
Id
0
0
z
4.4
0
4-D
r.
4)
4-b
iz
0
C.)
T.)
Z;
11-:1
r-O
40
r-4
r.
ra
0
5c
0
C)
Cd
Days
FIG. 7, 8, 9, IO.-Blood haemoglobin and 5'Cr-concentration in normal "August" rats
transfused with 0
-5 rnl. 5'Cr-labeRed red cefls or plasma from litter-mate donors bearing tumour R 2426.
0 Recipients receiving labeRed red ceR suspension.
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FIG. 7.-Blood taken fromdonor 4 days after implantation.
Range of 5'Cr-concentration in normal
" August
" rats transfused with 5'Cr.
labelled ceUs from litter-mate donors.235 RED CELL DESTRUCTION IN TUMOUR BEARING RATS
clear that the donor's cells are not involved to any great extent in thehaemolytic
episode which destroys the recipient's cells.
Transfusion ofplasma in all cases caused a haemolytic episode in the recipient
similar to that following transfusion of red ceRs but occurring about 4 days later
in time.
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Fig. II shows the results of anexperimentcomparing the effects ofintravenous
and intraperitoneal transfusion of 5'Cr-labelled cefls from tumour-bearing donors
to normal recipients. Intraperitoneally injected 5'Cr-labeRed ceRs rapidly appear in the circulation and their haemolytic activity does not appear to be decreased
by passage through the peritoneal cavity, since no difference may be observed
between the survival oflabelled cells in animals transfusedintravenously and that
that in animals transfused intraperitoneally.I __j
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In furtherexperiments,blood was taken from atumour-bearing animalshortly
before it was due to undergo its haemolytic episode and the labelled red cell sus-
pension diluted with isotonic saline. 0-5 ml. portions of the diluted suspension
were then transfused intravenously to normal recipients and the interval between
transfusion and the onset of haemolysis in the recipient measured. Results are
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summarised in Table 11. With dilution, the haemolytic activity of the donor's
blood is progressively reduced, as measured by the interval between transfusion
and the onset of haemolysis, but even at a dilution of x 1000, a haemolytic episode is still observed. This dilution corresponds to the transfusion of only 0-0005 ml. of blood.
The data ofFig. 7-10 may now be reconsidered in the light of these dilution
studies. Table III summarises the results of those experiments in which 0-5 ml.237 RED CELL DESTRUCTION IN TUMOUR BEARING RATS
TABLE II.-Interval Between Transfusion and Onset of Haemolytic Episode in
" August
" Rats Transfused with 0-5 ml. Wwhed Red Cell Suspension Taken
from Litter-mate Donor8 14 days After Implantation with Tumour R 2426
Interval between
transfusion and
onset of
haemolyticepisode
Material transfused Dilution (days)
Saline 1 No episode
Suspension of red cells from non-tumour-bearing donor 1 91 9
Suspension of red cells from tumour-bearing donor 1 3
Suspension of red cells from tumour-bearing donor 0.1 5
Suspension of red cells from tumour-bearing donor 0.01 7
Suspension of red cells from tumour-bearing donor 0.001 9
TABLE III.-Interval Between Transfusion and Onset of Haemolytic Episode in
August
" Rats Transfused with 0-5 ml. Washed Red Cell Suspenston Taken
from Litter-mate Donors at Different Times after Implantation with Tumour
R 2426
Interval between
Interval between transfusion and
implantation and onset of
transfusion haemolytic episode
(days) (days)
I No episode
3 12
4 9
9 3
14 2
19 4
35 10
of labelled red cells was transfused from tumour-bearing donors to normal reci-
pients at different times afterimplantation ofthe donors. Thehaemolytic activity
ofthe donor's blood as measured by therapidity with which it promotes a haemo-
lytic epigode increases to a maximum which is reached during or just after the
episode in the donor, and then slowly declines. Whilst the results ofexperiments
involving different donors are not strictly comparable, an approximate evaluation
of the relative haemolytic activity of the donor's blood at different times after
implantation may be made by comparison with the data of Table 11.
The relative effects ofinjections ofred cells and ofplasma which werereported
in Fig. 7-10 may be similarly evaluated. The results show that the haemolytic
agent ismainlyassociated with the cellularfraction and isonlyfound in theplasma
at a concentration lower by at least two orders ofmagnitude.
The effect ofmultiple transfusions.of red cellsfrom tumour-bearing donors to normal
recipients
Following theinduction of ahaemolyticepisode in an animalreceiving atumour
implant or a transfusion from a tumour-bearing animal, it has not been found
possible to induce a secondepisode eitherby transfusion orimplant. Fig. 12 shows
the results of an experiment in which labelled cells were transfused to normalI -I
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recipients from a tumour-bearing litter mate donor during its haemolytic episode
and caused the expected haemolytic response. Four weeks later, the recipients
were transfused with 5'Cr-labelled red cells from a second tumour-bearing litter
mate donor also undergoing its haemolytic response. On this occasion, no haemo-
lytic episode is observed, although the same red cell suspension injected into the
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animals previously transfused did not fail to produce the expected pattern of
haemolysis.
Such protection has been found to extend at least up to two months after the
initial haemolytic response. It has already been described how labelled red cells
transfused from a tumour-bearing donor which has undergone its haemolytic
episode to a normal recipient have a normal or near-normal survival (Fig. 10).
although ahaemolyticepisode is induced in therecipient. This is a furtherexample239 RED CELL DESTRUCTION IN TUMOUR BEARING RATS
oftheprotection afforded to the red cells of an animalthat hasundergone a haemo-
lytic episode.
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-5 ml. 5"Cr-labelled red cells from tumour-bearing litter-mate donor 4 days after
implantation of latter with tumour R 2426.
* Injection by intraperitoneal route.
* Injection by intravenous route.
I/ Range of5'Cr-concentration in normal
"August
" rats transfused with "'Cr-labeRed
cells from litter-mate donors.
DISCUSSION
In the abserice of the results of serological studies which are still incomplete, detailed discussion of the mechanisms underlying the phenomena described must
be speculative. However, it is clear that the haemolytic episode and anaemia
observed after implantation ofthe tumour R 2426 do not resemble that described
by Greenfield and his co-workers, since no accumulation of 51Cr in the tumour is
observed after transfusion of -5'Cr-labelled red cells.240 E. H. BELCHER AND SHIRLEY M. SIMPSON
The haemolytic episode has some features in common with those observed in
auto-immunehaemolytic anaemias attributed to the presence ofincomplete warm
agglutinins (Dacie, 1954; Jandl, Jones and Castle, 1957), notably the accumula-
Days
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FiG. 12.-Blood haemoglobin and 51Cr-concentration in normal
" August
" rats transfused
on two occasions at an interval of 4 weeks with 0
- 5 ml. -I'Cr-labelled red cells from tumour-
bearing litter-mate donors 10 days after implantation of latter with tumour R 2426.
A Response to first transfusion.
B Response to second transfusion.
Z 71 Range of -"Cr-concentration in normal
"August
" rats transfused with "Cr-labelled
ceHs from litter-mate donors.
tion of 51Cr on the liver and spleen during the episode. Such agglutinins might
be evoked in response to the tumour graft in a manner similar to that in which
antibodies to tumour or skin homografts which may be titrated as haemagglu-
tinins are produced in mice (Hildeman and Medawar, 1959). Alternatively, they
might beproducedby the tumour itselfagainst the host animal's cells assuggy-ested.0
-t
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by Green, Wakefield and Littlerwood (1958). In either of these situatioiis, the
induction ofhaemolysis in a normal animal receiving a transfusion of blood from
atumour-bearing donor would be due to the transfer ofantibody from the donor's
red ceRs to those of the recipient. However, it has been demonstrated that a
haemolyticepisode can follow the transfusion of as little as 0-005 ml. ofblood and
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it appears improbable that sufficient antibody could be transferred by such a mechanism to cause the haemolysis ofnearly all the host's cells.
A further possibility is that the tumour might produce an antigen similar or
complementary to antigenic components on the host"s red cells. Antibodies pro- duced by the host against this antigen might then induce agglutination of the red
cells. The antigen could be transferred with the blood of a tumour-bearing donor
to a normalrecipient and induce a similarproduction ofantibodyandagglutinatioli oftherecipient's red cells. However, thefinding that-the time between transfusion242 E. H. BELCHER AND SHIRLEY M. SIMIPSON
and onset of the haemolytic episode may be as little as two days does not seem to
be compatible with such a mechanism.
The observations that the haemolytic activity of the blood increases steadily
with time after implantation of tumour and that a haemolytic episode can follow
the transfusion of minute amounts of blood from a tumour-bearing donor to a
normal recipient suggest that the responsible agent is some factor, possibly viral
in nature, which is capable of multiplication within the host. If such is the case,
the question must be asked whether the virus is the causative agent ofthe tumour
or whether it exists concomitantly in the tumour tissue but without aetiological
relationship to it (Zilber, 1958). Further studies designed to test all ofthese possi-
bilities are being carried out.
SUMMARY
Rats of the " August " strain bearing the transplantable adenocarcinoma
R 2426 undergo an acute haemolytic episode 10-15 days after implantation of
tumour. This phenomenon has been investigated by radioactive tracer techniques
with 5'Cr and 59Fe. Cells are destroyed randomly without regard to age during
the haemolytic episode. Destroyed red cells accumulate primarily in the liver
and spleen, destruction in the vascular bed ofthe tumour being absent or extremely
small.
A similar haemolytic episode may be induced in normal animals transfused
intravenously or intraperitoneally, with blood from tumour-bearing litter-mate
donors. The rapidity of onset of the episode is related to the amount of blood
transfused and to the time after implantation at which the blood is taken from
the donor.
After an initial haemolytic episode induced by implant or transfusion, it is
impossible to induce a second episode in the same animal; furthermore, red cells
from a tumour-bearing donor which has suffered a haemolytic episode show near-
normal survival when transfused to normal recipients, although they provoke a
haemolytic episode in the recipient.
The mechanisms by which these phenomena are brought about are discussed.
This work has been carried out in part at the Institute of Cancer Research,
Royal Cancer Hospital, and in part at the Postgraduate Medical School, and has
latterly been supported by a grant from the British Empire Cancer Campaign.
The technical assistance ofMr. H. C. Christie, Miss Frances Holmes and Miss Judith
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